EDGAR Filing Documents for 0001470930-09-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001470930-09-000001

Filing Date

2009-09-04

Accepted

2009-09-04 12:36:49

Documents

Effectiveness Date

2009-09-04

Items

Item 06: Rule 506

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	5727
	Complete submission text file	0001470930-09-000001.txt		7186

Mailing Address 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA 94547

Business Address 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA 94547 510 724 1548

BIOXINESS PHARMACEUTICALS, INC. (Filer) CIK: 0001470930 (see all company filings)